Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |